{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:00:29Z","timestamp":1790834429140,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The prevalence of pathogenic variants in disease-related genes is population-specific and is of vital importance for the development of national health policies. It is especially important with medically actionable diseases, where early interventions and preventive surveillance are available and can enable effective preventive measures or timely treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>We have examined the burden of pathogenic variants in 84 genes associated with medically actionable disease in exome sequencing data of 14.000 Slovenian individuals, representing 0.7% of the whole Slovenian population. The variants were classified according to the ACMG criteria, and the prevalence of pathogenic variants in each gene was compared to the burden of pathogenic variants in the gnomAD database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of pathogenic variants in 84 medically actionable genes in the Slovenian population is 2.73%. Furthermore, we identified an additional 0.48% of novel candidate likely pathogenic variants. Together, these variants accounted for 3.21% of all detected potentially medically actionable variants. Of this variation, 1.73% is cardio-related, 1.21% is cancer-related, and 0.27% is associated with other phenotypes. The prevalence of pathogenic variants in\n                      <jats:italic>BRCA1, LDLR,<\/jats:italic>\n                      and\n                      <jats:italic>HFE<\/jats:italic>\n                      differs significantly between the Slovenian population and the gnomAD database.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Revealing the prevalence of pathogenic variants in medically actionable genes in the Slovenian population highlights the need for careful interpretation of genomic data in our population, as approximately one in 31 individuals carries a potentially medically actionable variant. Our results advocate for population-specific evaluation of genetic disease burden, as tailored measures, particularly for genes enriched in a given population, may be warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2026.1847596","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:41:32Z","timestamp":1790833292000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Burden of pathogenic variants in genes associated with medically actionable disease in the Slovenian population"],"prefix":"10.3389","volume":"17","author":[{"given":"Ur\u0161ka","family":"Kotnik","sequence":"first","affiliation":[{"name":"Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana","place":["Ljubljana, Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Lovrecic","sequence":"additional","affiliation":[{"name":"Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana","place":["Ljubljana, Slovenia"]},{"name":"Faculty of Medicine, University of Ljubljana","place":["Ljubljana, Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borut","family":"Peterlin","sequence":"additional","affiliation":[{"name":"Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana","place":["Ljubljana, Slovenia"]},{"name":"Faculty of Medicine, University of Ljubljana","place":["Ljubljana, Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","article-title":"Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion","volume":"39","author":"Abou Tayoun","year":"2018","journal-title":"Hum. Mutat."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/s41436-019-0502-5","article-title":"The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American college of Medical Genetics and Genomics (ACMG)","volume":"21","year":"2019","journal-title":"Genet. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1101\/gr.183483.114","article-title":"Actionable exomic incidental findings in 6503 participants: challenges of variant classification","volume":"25","author":"Amendola","year":"2015","journal-title":"Genome Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/life11030205","article-title":"Whole-genome sequencing in diagnostics of selected Slovenian undiagnosed patients with rare disorders","volume":"11","author":"Bergant","year":"2021","journal-title":"Life (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/genes17040472","article-title":"Enrichment of rare variants in nuclear-encoded mitochondrial metabolism genes in patients with early-onset or familial Parkinson\u2019s disease","volume":"17","author":"Bergant","year":"2026","journal-title":"Genes (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"eadg7492","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e866","DOI":"10.1002\/ctm2.866","article-title":"Identification of clinically actionable secondary genetic variants from whole\u2010genome sequencing in a large scale Chinese population","volume":"12","author":"Cong","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2350-8-69","article-title":"Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay","volume":"8","author":"Cukjati","year":"2007","journal-title":"BMC Med. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00439-004-1152-4","article-title":"The origin and spread of the HFE-C282Y haemochromatosis mutation","volume":"115","author":"Distante","year":"2004","journal-title":"Hum. Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes \u2014 association analysis in more than 113,000 women","volume":"384","author":"Dorling","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41591-021-01672-4","article-title":"A roadmap to increase diversity in genomic studies","volume":"28","author":"Fatumo","year":"2022","journal-title":"Nat. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41436-020-0810-9","article-title":"Frequency of genomic secondary findings among 21,915 eMERGE network participants","volume":"22","author":"Gordon","year":"2020","journal-title":"Genet. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e70143","DOI":"10.1002\/mgg3.70143","article-title":"Frequency and spectrum of actionable secondary findings in the Maltese population","volume":"13","author":"Grech","year":"2025","journal-title":"Mol. Genet. Genomic Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","article-title":"ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing","volume":"15","author":"Green","year":"2013","journal-title":"Genet. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/S41436-018-0028-2","article-title":"Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC science impact framework","volume":"21","author":"Green","year":"2019","journal-title":"Genet. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/gim.2017.121","article-title":"Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes","volume":"20","author":"Grosse","year":"2018","journal-title":"Genet. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41586-022-04965-x","article-title":"The sequences of 150,119 genomes in the UK Biobank","volume":"607","author":"Halldorsson","year":"2022","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/jpm12091503","article-title":"Landscape of secondary findings in Chinese population: a practice of ACMG SF v3.0 list","volume":"12","author":"Huang","year":"2022","journal-title":"J. Personalized Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/gbe\/evaa021","article-title":"Population-specific genetic and expression differentiation in Europeans","volume":"12","author":"Jiang","year":"2020","journal-title":"Genome Biol. Evol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics","volume":"19","author":"Kalia","year":"2017","journal-title":"Genet. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1038\/s41598-023-32397-8","article-title":"Assessment of pathogenic variation in gynecologic cancer genes in a national cohort","volume":"13","author":"Kotnik","year":"2023","journal-title":"Sci. Reports"},{"key":"B24","doi-asserted-by":"publisher","first-page":"101454","DOI":"10.1016\/j.gim.2025.101454","article-title":"ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"27","author":"Lee","year":"2025","journal-title":"Genet. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"41118","DOI":"10.1038\/s41598-025-24991-9","article-title":"Creating the Slovenian genome database and browser as a source of comprehensive variation of the Slovenian population","volume":"15","author":"Maver","year":"2025","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","article-title":"ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.gim.2022.04.006","article-title":"ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"24","author":"Miller","year":"2022","journal-title":"Genet. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"100866","DOI":"10.1016\/j.gim.2023.100866","article-title":"ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Miller","year":"2023","journal-title":"Genet. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fpubh.2018.00247","article-title":"The evolution of public health genomics: exploring its past, present, and future","volume":"6","author":"Molster","year":"2018","journal-title":"Front. Public Health"},{"key":"B30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"101225","DOI":"10.1016\/j.gim.2024.101225","article-title":"Secondary ACMG and non-ACMG genetic findings in a multiethnic cohort of 16,713 pediatric participants","volume":"26","author":"Saeidian","year":"2024","journal-title":"Genet. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/s41431-018-0200-9","article-title":"Incidental or secondary findings: an integrative and patient-inclusive approach to the current debate","volume":"26","author":"Saelaert","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e250917","DOI":"10.1001\/jamanetworkopen.2025.0917","article-title":"Genomic screening at a single health system","volume":"8","author":"Savatt","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"B34","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00277-008-0463-2","article-title":"Distribution of HFE gene mutations in Slovenian patients with hereditary hemochromatosis","volume":"87","author":"Stepec","year":"2008","journal-title":"Ann. Hematol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/j.gim.2022.06.010","article-title":"Universal screening for familial hypercholesterolemia in 2 populations","volume":"24","author":"Sustar","year":"2022","journal-title":"Genet. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/cancers17050742","article-title":"Evaluation of the Slovenian breast cancer screening programme: years of life gained and avoided deaths","volume":"17","author":"Tom\u0161i\u010d","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.56367\/oag-050-12557","article-title":"The genome of Europe project for Pan-European population genomics","volume":"50","author":"Uitterlinden","year":"2026","journal-title":"Open Access Gov."},{"key":"B38","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41586-020-2853-0","article-title":"Exome sequencing and characterization of 49,960 individuals in the UK Biobank","volume":"586","author":"Van Hout","year":"2020","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s42003-023-05708-y","article-title":"The frequency of pathogenic variation in the all of us cohort reveals ancestry-driven disparities","volume":"7","author":"Venner","year":"2024","journal-title":"Commun. Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"ckae144.778","DOI":"10.1093\/eurpub\/ckae144.778","article-title":"The 1+Million genomes maturity level model for genomics in healthcare","volume":"34","author":"Vicente","year":"2024","journal-title":"Eur. J. Public Helath"},{"key":"B41","volume-title":"Ugotavljanje in Analiza Genetskih Vzrokov Kardiomiopatij S Pristopom Sekvenciranja Naslednje Generacije","author":"Vodnjov","year":"2025"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1847596\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:41:33Z","timestamp":1790833293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1847596\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":41,"alternative-id":["10.3389\/fgene.2026.1847596"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1847596","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1847596"}}